Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Theratechnologies Inc is a pharmaceutical company addressing unmet medical needs in metabolic disorders. EGRIFTA is its registered trademark in the USA and it is used to commercialize its first product using its internally developed compound, tesamorelin.
Price: $1.25 | Change: +$0.06 | %Change: +5.04%
Volume: 731,850 | Day High/Low: 1.28/1.14 | 52 Week High/Low: 1.30/0.325
View modes: 
0 stars

Off topic

3 cheers for the Habs.  EOM  rate and reply
1.5 stars


that was a good close. Folks no stock goes up or down or up endlessly and we are not even close to the crescendo on the upside in my humble opinion. The markets have just started speaking by more
0 stars


Yes I know Havenger Google Translation is not perfect nor is my grammer and spelling in both languages for that matter but at least it gives you an idea. Thanks for the advice Havenger but I more
0 stars


"Palinc en toute honêteté avant j'étais pareille voila beaucoup d'années passés. Saint si passe pis crace je me cassais la tête en deux sur quelque que j'ai aucun controle dessus encore pire more
1 star


Palinc en tout respect mon ami we have no control over that that's their own decisions. Personally I don't even worry about that other than taking my own decisions using technical analysis tools at more
0 stars


As of right now UBS has sold 2.2 million shares since April 1 gotta be getting close to running out if they haven't already  rate and reply
0 stars


JFM is not blasting UBS for selling He is just stating the fact that in spite if all the great fundamentals the SP is not rising mainly due to the imbalance between Sellers and Buyers resulting more
0 stars


Just to add on that, today's seller may just become tomorrow's buyers and vice versa, at the end of the day we are all traders in the stock market within our set guidelines, I know one thing that more
0 stars


JFM why do you worry so much over things that you have no control over whatsoever other than your own actions ? Let them sell or buy shares of TH it's there business and if they made money more
0 stars


UBS is still unloading. No significant rise will be possible until they dry up. They badly want to take profit.  rate and reply
0 stars

RE:SC of Canada ruled in favor of Theratechnologies

No surprise with th SC decision. Investors needs to understand in what they are investing.  rate and reply
0 stars

SC of Canada ruled in favor of Theratechnologies

MONTREAL, CANADA--(Marketwired - Apr 17, 2015) - Theratechnologies Inc. (TH.TO) announced today that the Supreme Court of Canada has granted its appeal and dismissed 121851 Canada Inc.'s motion more
0 stars

RE:RE:RE:RE:RE:SPCE, Will they beat the street....

Thanks Juniper, from my behalf I truly appreciate that you answered & tried. Maybe someone else on the bullboard would know ? Best regards, Ti-Butch  rate and reply
0 stars

RE:RE:RE:RE:SPCE, Will they beat the street....

Unfortunately I do not have a link.  rate and reply
0 stars

RE:Long term potential

Thanks Palinc, yes I vividly remember reading that but after verifying my 2007 income tax statements I was almost completely out of TH in June 07 and was still following their developments at more
0 stars

RE:RE:RE:SPCE, Will they beat the street....

Thanks Juniper, you may have missed my question a few days a go.... Do you a have link or something pertaining to Bluebird ? It could give us some sort of guidance on sales even if they are more
0 stars

RE:RE:SPCE, Will they beat the street....

Rusty, I believe the analyst's revenue estimate of $6.45 million is in Canadian $.  The $6.7 million for 800 patients is in U.S. $ Luc stated that according to bluebird there are now 130 to more
0 stars

Long term potential As far as I know there has been no published update to the 2007 study. Surely the company has an update but they more
0 stars

SPCE ....

I might be reading to much on Mr Tanguay's statement could mean starting at 9:10 to 9:34 of the CC but I can only presume that Q2 ending May 31st could be the company's best ever quarter of more
0 stars

TH should buy PDP then sp will explode

Pediapharm (PDP.V) has already 6 Products on the Market .The Market Cap of $24 Million is really a Big Joke this Stock is one of the most Attractive Biotech in Canada. The Asthma Drug more